Dr. Ingrid M. Meszoely, MD

Dr. Meszoely practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Meszoely's NPI, 1225120645, was assigned on September 30, 2006. Dr. Meszoely graduated from Boston University School of Medicine in 1993. Dr. Meszoely holds Tennessee license MD31091.

Dr. Meszoely's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Meszoely's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Meszoely to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meszoely practices, 2 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Meszoely's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Meszoely is licensed in Tennessee.

CMS data shows 130 Medicare services from Dr. Meszoely across 6 procedure codes in 2024, for 91 Medicare patients. Medicare paid $14,093 for them.

CMS counts 91 Medicare patients who saw Dr. Meszoely in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have cancer, and 70% have high cholesterol. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Meszoely's median patient age at 65, with 98% women.

In 2018, Dr. Meszoely wrote 12 Medicare Part D claims. They cover 1 drug, with $335 in total drug cost. In 2016, CMS named 18 claims across 1 drug.

Dr. Meszoely accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of mastectomy by Dr. Meszoely, more than 85% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 39 papers to Dr. Meszoely, published from 2011 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Magnetic Resonance Imaging and Breast. Dr. Meszoely has published most often in Proc SPIE Int Soc Opt Eng. Dr. Meszoely's most frequent co-authors are Vandana Gupta Abramson, MD, Mark C. Kelley, MD and Raeshell Sharawn Sweeting, MD.

Dmand AI links Dr. Meszoely to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 22 general payments to Dr. Meszoely from 3 drug and device companies from 2017 to 2024. Travel and lodging make up the largest share, 79% of the total. Intuitive Surgical, Inc. paid the most, $1,452.

Dr. Meszoely graduated from Boston University School of Medicine in 1993.